Generation of factor VIII cofactor activity requires divalent metal ions such as
Factor VIII, a plasma protein that participates in the blood coagulation cascade, is decreased or defective in individuals with hemophilia A. Factor VIII functions as a cofactor for the serine protease factor IXa in the surface-dependent conversion of zymogen factor X to the serine protease, factor Xa (1, 2). Deficiency of factor VIII activity results in a marked reduction of factor IXa activity and in the subsequent rates of factor Xa generated during the propagation phase of coagulation.
Factor VIII is synthesized as an ϳ300-kDa single chain precursor protein (3, 4) with domain structure A1-A2-B-A3-C1-C2 (5) . Factor VIII is processed to a series of divalent metal ion-linked heterodimers (6 -8) by cleavage at the B-A3 junction, generating a heavy chain (HC) 1 minimally represented by the Al-A2 domains; and a light chain (LC) consisting of the A3-C1-C2 domains. The A domains of factor VIII share homology with the A domains of factor V and the copper-binding protein, ceruloplasmin (9) . One mole of copper has been identified in factor VIII (10, 11) . Metal ions play an important role in regulating factor VIII structure and activity. Factor VIII is inactivated by EDTA, which facilitates dissociation of the HC and LC (6, 8) . Active factor VIII can be reconstituted by combining the isolated subunits in the presence of Ca 2ϩ or Mn 2ϩ (12) (13) (14) . In addition, the presence of low levels of Cu ϩ or Cu 2ϩ stimulates this effect (11, 15) . Thus, it was thought that the linkage of HC and LC by a metal ion (Ca 2ϩ , Mn 2ϩ , or Cu 2ϩ ) formed an active heterodimer. This interpretation was consistent with studies examining the reconstitution of factor Va from isolated subunits by Ca 2ϩ or Mn 2ϩ (16, 17) . We recently evaluated the metal ion-dependent and independent association of factor VIII chains (18) . In the absence of metal ions, LC and HC combine to form an inactive heterodimer as demonstrated by fluorescence energy transfer. Ca 2ϩ had little effect on inter-subunit affinity, yet converted the inactive dimer to an active, although low specific activity, form. Alternatively, Cu 2ϩ enhanced the inter-subunit affinity ϳ100-fold but yielded a dimer lacking cofactor activity. However, the presence of both metal ions resulted in a high intersubunit affinity and yielded high specific activity factor VIII. A recent study on the role of Ca 2ϩ in factor VIII indicated that Ca 2ϩ binding to both factor VIII chains was required for the generation of cofactor activity (19) . These studies also demonstrated a local conformational change in response to Ca 2ϩ binding correlated with formation of the active cofactor. Factor VIII activity is also reconstituted following addition of Mn 2ϩ (12) . However, the Mn 2ϩ binding site appeared non-identical to the Ca 2ϩ binding site, based upon phosphorescence studies showing differential competition by Tb 3ϩ (20) . Ca 2ϩ -binding proteins typically coordinate Ca 2ϩ by 6 -8 ligands comprising side chain carboxyl oxygen of acidic amino acids and carbonyl oxygen from the peptide bond (21) . Although Ca 2ϩ binding motifs have been identified, many Ca 2ϩ -binding proteins coordinate the ion at sites other than a consensus sequence. Recently it was reported that residues 94 -110 in factor V, a region rich in acidic amino acids, bound Ca 2ϩ , promoting the association of factor Va HC and LC (22) . An homologous region in factor VIII, residues 110 -126, contains 4 Asp and 4 Glu residues in the 16-residue segment.
In the present study, we show that Ca 2ϩ binding to the A1 domain of factor VIII is critical for activity generation and directly demonstrate this binding by ITC using the isolated A1 subunit of factor VIIIa. Site-directed mutagenesis is employed to identify residues important in Ca 2ϩ binding to factor VIII and resultant effects of this binding on activity. Results of this study identify several acidic amino acids within segment 110 -126 of the A1 domain of factor VIII that are likely to participate in the coordination of Ca 2ϩ necessary for generation of maximal cofactor specific activity. Furthermore, comparative data examining Mn 2ϩ binding suggest that this ion binding site partially overlaps with the Ca 2ϩ site. Based upon these data, we propose a model whereby occupancy of the metal ion binding site stabilizes a conformation between the A1 and C1 domains in the cofactor.
MATERIALS AND METHODS
Reagents-Recombinant factor VIII (Kogenate TM ) was a gift from Dr. Lisa Regan of Bayer Corp. (Berkeley, CA). Phospholipid vesicles containing 20% phosphatidylserine, 40% phosphatidylcholine, and 40% phosphatidylethanolamine were prepared using octylglucoside as described previously (23) . The reagents ␣-thrombin, factor IXa␤, factor X, and factor Xa (Enzyme Research Laboratories, South Bend, IN), hirudin, phospholipids, MnCl 2 (Sigma), and the chromogenic Xa substrate S-2765 (N-␣-benzyloxycarbonyl-D-arginyl-glycyl-L-arginyl-p-nitroanilide dihydrochloride; DiaPharma, West Chester, OH) were purchased from the indicated vendors. The B-domainless factor VIII (FVIIIHSQ) expression construct HSQ-MSAB-NotI-RENeo was a gift kindly provided by Dr. Pete Lollar and John Healey.
Preparation of Factor VIII and Subunits-Factor VIII LC, HC, A1, and A2 subunits were isolated from factor VIII as previously described (24) . Proteins were dialyzed into 10 mM MES, 0.3 M KCl, 0.01% Tween 20, pH 6.5, and stored at Ϫ80°C.
Construction, Expression, and Purification of Factor VIII Mutants-B-domainless factor VIII cDNA was restricted from the factor VIII expression construct HSQ-MSAB-NotI-RENeo, using the endonucleases XhoI and NotI, and cloned into the Bluescript II K/SϪ vector. Factor VIII molecules bearing single point mutation of 3 Ala, were constructed. Mutations were introduced into the shuttle constructs using the Stratagene QuikChange site-directed mutagenesis kit as described (25) . Upon confirmation of the presence of only the desired mutations by dideoxy sequencing, the appropriate fragment was restricted and cloned back into the factor VIII expression construct. Presence of only the desired mutations was confirmed by a second round of dideoxy sequencing (Integrated DNA Technologies, Coralville, IA).
The factor VIII expression vector constructs were transfected in baby hamster kidney cells using FuGENE 6 (Roche Molecular Biochemicals). The selection, subcloning, and cloning of stable transfectants were performed by standard methods, and the cloned cells were cultured in roller bottles (25) . The conditioned medium was collected daily, and the expressed proteins were purified using a one-step chromatography scheme as follows. The conditioned medium (ϳ0.3 liter) was centrifuged at 3,000 ϫ g for 20 min, and the supernatant was filtered through a 0.22-m filter. The pH of the filtrate was adjusted to 6.0, and material was loaded onto a column of SP-Sepharose (5 ml; Amersham Biosciences) equilibrated with 10 mM MES, pH 6.0, 0.2 M NaCl, 0.01% Tween 20. After washing with 20 mM HEPES, pH 7.2, 0.2 M NaCl, 0.01% Tween 20, the bound factor VIII was eluted by with 20 mM HEPES, pH 7.2, 0.8 M NaCl, 0.01% Tween 20. Active fractions were detected using a one-stage clotting assay, pooled, and dialyzed against 10 mM MES, pH 6.5, 0.3 M KCl, 0.01% Tween 20 in Chelex 100-treated double-distilled H 2 O. Resultant factor VIII forms were typically Ͼ80% pure as judged by SDS-polyacrylamide gel electrophoresis, with albumin representing the major contaminant. Factor VIII samples were quick frozen and stored at Ϫ80°C.
Factor Xa Generation Assays-The rate of conversion of factor X to factor Xa was monitored in a purified system (26) according to the method previously described (18, 19) . Activity was determined as the amount of factor Xa generated (nM) per minute and converted to a value per nM factor VIII. and EDTA concentrations were 0.3 mM and 4 M, respectively). At the indicated times, aliquots were removed and the activity was measured by the factor Xa generation assay.
Preincubation of Factor VIIIa Subunits with Ca
Isothermal Titration Calorimetry for Ca 2ϩ Binding on A1-ITC was performed to measure Ca 2ϩ binding to the isolated A1 subunit using a VP-ITC MicroCalorimetry Systems Instrument (MicroCal, Northampton, MA). The concentration of A1 was determined by A 280 value using an extinction coefficient ϭ 58,350 cm Ϫ1 M Ϫ1 based upon the amino acid sequence for the A1 domain (factor VIII residues 1-372) according to the method of Gill and von Hippel (27) . A1 subunit (25.6 M) was treated with 10 mM EDTA for 18 h at 4°C, followed by dialysis against 10 mM MES, pH 6.5, 0.3 M KCl, 0.01% Tween 20. The dialysis buffer was made using Chelex 100-treated H 2 O, and the system was extensively washed with Chelex 100-treated H 2 O prior to use. Samples and buffers were degassed prior to analysis. The A1-containing solution was placed in a 1.44-ml sample cell. A 700-l syringe loaded with 2 mM CaCl 2 in the same buffer was used for a series of automatic injections of 2 l each into the A1 solution while mixing at a rate of 290 rpm at 30°C. The cumulative total of the heat evolved was plotted against the total Ca 2ϩ concentration to produce a binding isotherm. Each injection was followed by a 240-s pause to allow the system to return to a base-line value. Because heat produced from dilution, as measured by injecting the Ca 2ϩ solution into the sample cell containing only the buffer, was negligible, the uncorrected data were used for the analysis. An identical independent binding site model was fit to the data and thermodynamic parameters (enthalpy (⌬H 0 ), K d , and molar binding stoichiometry (n)) were determined by nonlinear least squares regression using ORIGIN software. Subsequently Gibbs free energy (⌬G) and entropy (⌬S 0 ) were calculated from the fitted values.
Factor VIII Activity Titration Using Ca 2ϩ or Mn 2ϩ -Ca 2ϩ -EGTA buffer with free Ca 2ϩ concentrations of 0 -6.5 mM and Mn 2ϩ -EGTA buffer with free Mn 2ϩ concentrations of 0 -0.75 mM in the presence of 2 mM EGTA were prepared as previously described (19, 20) . Wild type or mutant HSQ factor VIII (50 nM) was reacted in the Ca 2ϩ -EGTA buffer or Mn 2ϩ -EGTA buffer at 4°C for 18 h, and resultant factor VIII activity was measured using the factor Xa generation assay. Non-linear least
FIG. 1. Effect of preincubation with Ca
2؉ on factor VIIIa reconstitution from isolated subunits. Factor VIIIa subunits (A1/A3-C1-C2 and A2) were separately preincubated with 3 mM Ca 2ϩ or 0.1 mM EDTA for 18 h. After mixing the preincubated A1/A3-C1-C2 and A2, reconstituted factor VIII activity was measured by a factor Xa generation assay as described under "Materials and Methods." Mixtures were A1/A3-C1-C2 preincubated with Ca 2ϩ plus A2 preincubated with Ca Enzyme-linked Immunosorbent Assay-A sandwich ELISA was preformed to measure the concentration of HSQ factor VIII proteins (25) . The procedure employed ESH8 (anti-factor VIII LC antibody; American Diagnostica) as a capture antibody and biotinylated R8B12 (anti-factor VIII A2 antibody; Green Mountain Antibodies) as the detection antibody. Thus, the epitopes for these antibodies are far removed from the sites of mutagenesis. The amount of bound factor VIII was determined optically using a streptavidin-linked horseradish peroxidase (Calbiochem) with the substrate O-phenylenenediamine dihydrochloride, (Calbiochem) as previously described (25) . Purified commercial recombinant factor VIII was used as the standard to determine the concentration of the samples. Factor VIII specific activity was determined from onestage clotting assays and ELISA and is expressed as units/g.
Statistical Analysis-Nonlinear least squares regression analysis was performed by Kaleidagraph (Synergy, Reading, PA) to obtain parameter values and standard deviations.
RESULTS

Preincubation of Factor VIIIa Subunits with Ca
2ϩ or EDTA Followed by Activity Reconstitution-Previously we demonstrated that maximal cofactor activity was achieved only when both HC and LC were preincubated with Ca 2ϩ (19) , suggesting that Ca 2ϩ binding to both HC and LC was necessary to generate active factor VIII. A similar evaluation of factor VIIIa reconstitution from the isolated A1, A2, and A3-C1-C2 was performed to determine the Ca 2ϩ requirement for the HC-derived A1 and A2 subunits in activity generation. The reconstitution of factor VIIIa is a two-step process with the initial association of A1 and A3-C1-C2 comprising the rate-limiting step and requiring several hours to complete (28) . Therefore, we completed this first step by mixing A1 and A3-C1-C2 subunits (2:1, mol:mol) in the presence of either 3 mM Ca 2ϩ or 0.1 mM EDTA for 18 h. Activity generation was then monitored following the addition of A2 subunit, which, like the other subunits, was preincubated with either 3 mM Ca 2ϩ or 0.1 mM EDTA. The reconstituted A1/A3-C1-C2 dimer and A2 subunit were diluted 50-fold prior to reconstitution to prevent the EDTA-treated component from acquiring Ca 2ϩ at the time of reconstitution. Furthermore, the reconstitution time course (30 min) was short enough so that the dissociation of Ca 2ϩ from subunits upon their dilution was not a concern. Evaluation of the negative control (both A1/A3-C1-C2 dimer and A2 subunit pretreated with EDTA) did not generate any activity over the reconstitution time course (Fig. 1) . On the other hand, recombining the Ca 2ϩ -treated A1/A3-C1-C2 dimer and A2 subunit resulted in the rapid generation of factor VIIIa activity (Fig. 1) that reached a maximal level within 10 min. When Ca 2ϩ -treated A1/A3-C1-C2 was associated with EDTA-treated A2, the generated activity was similar to the positive control (ϳ90% activity at 10 min and ϳ80% activity at 30 min). Assuming the association rates for Ca 2ϩ binding on each subunit was similar, these data suggested that there was little if any contribution of Ca 2ϩ binding to A2 subunit for activity generation. Consistent with this result was the failure to reconstitute factor VIIIa activity with the Ca 2ϩ -treated A2 plus EDTA-treated dimer. These results, taken together with our earlier observation on the requirement for Ca 2ϩ binding to HC for efficient factor VIII reconstitution (19) to isolated A1 subunit was directly examined using ITC. Initial Ca 2ϩ injections into the A1-containing solution showed a large exothermic peak (Fig. 2) , providing direct evidence for binding of the metal ion to the factor VIIIa subunit. Data were fitted using an identical independent binding site model for cautious interpretation. Binding Site in A1-The above data indicate the presence of a Ca 2ϩ site(s) within the A1 domain of factor VIII that is (are) required for cofactor activity. Based upon the homology of factor VIII residues 110 -126 to the residues comprising a putative Ca 2ϩ binding site localized in factor V, we constructed a series of point mutations where acidic residues were replaced with Ala (or in some cases Asp). The stable transfectants were expressed as B-domainless factor VIII in baby hamster kidney cells, and recombinant factor VIII was purified as described under "Materials and Methods." The freshly purified factor VIII preparations (mutants and wild type) were dialyzed against metal ion-free buffer, and specific activity values were determined by one-stage clotting and sandwich ELISA assays (Table I ). This treatment resulted in the retention of a significant level of activity, as judged by a specific activity of 4.8 units/g for the wild type factor VIII, while removing exogenous metal ions from the protein preparations. The activity observed under these conditions likely reflected retention of a metal ion(s), possibly Ca 2ϩ , which is (are) not readily released in the absence of chelators. This property is not the result of the presence of single chain factor VIII (ϳ30 -50% of total factor VIII) in the recombinant preparations because partial purification of the factor VIII to enrich for single chain material yielded a similar specific activity as the unfractionated factor VIII preparation (data not shown).
Several of the Ala-substituted point mutations (E110A, D116A, E122A, D125A, and D126A) exhibited marked reductions in specific activity to levels of ϳ4 -12% of the wild type value (Table I) . Thus, the reduction in volume of the side chain and/or loss in electrostatic potential may result in slight conformational changes within this region that impair cofactor activity. Because results from a prior study evaluating a Ca 2ϩ site in lactalbumin showed the importance of side chains when replacing critical residues (29), we made selected, additional mutants with the conservative substitution of Asp for Glu at residues 110 and 122. As shown in Table I , significantly greater activity was retained in the E110D and E122D mutants (10.1 and 22.4%, respectively) compared with E110A and E122A mutants (3.8 and 12.2%, respectively).
Cofactor Activity Generated from Factor VIII Mutants following Titration with Ca 2ϩ -Our prior studies examining Ca 2ϩ binding in factor VIII employed isolated HC and LC prepared from the EDTA-treated heterodimer (18, 19) . Mixing of chains in the absence of Ca 2ϩ resulted in no regenerated activity. In the current study, limitations in the amounts of mutant factor VIII precluded chain separation and purification. However, we observed that the basal activity of the factor VIII measured in the absence of exogenous metal could be increased ϳ2-3-fold with saturating levels of Ca 2ϩ . This incremental activity increase provided a functional assay for the binding of Ca 2ϩ to the factor VIII A1 domain mutants. 
Ca 2ϩ Binding Site in the A1 Domain of Factor VIII
Increases in cofactor activity for the factor VIII wild type and 110 -126 mutants in the absence of exogenous metal ion were determined following titration with Ca 2ϩ . Results are presented in Fig. 3 and are arbitrarily divided into high, moderate, and low activity factor VIII forms. Estimated parameter values determined by nonlinear least-squares curve fitting are listed in Table II . An optimized range of Ca 2ϩ concentrations (0 -6.5 mM) was selected to cover the complete change in activity for all factor VIII forms. We observed no significant increase in activity at higher concentrations of Ca 2ϩ (Ͼ10 mM; data not shown). The k value indicates the difference between maximum activity at saturation with Ca 2ϩ and minimum activity with no exogenous metal ion present (C value). Therefore, the k value was used as an indicator to assess the activity response for each mutant to added Ca 2ϩ . Wild type factor VIII and many factor VIII mutants displayed an increase in activity in response to increases in the concentration of Ca 2ϩ . Maximal activity response for the wild type reflected a high affinity for Ca 2ϩ (K d ϭ 1.18 M, Table II ) and this value compared favorably with a K d ϭ 8.9 M for Ca 2ϩ binding as measured in a functional assay for reconstituted factor VIII HC and LC (19) , as well as with the value determined above from ITC analysis of the isolated A1 subunit. Two mutations (E113A and E122D) showed little deviation from the wild type affinity parameters. On the other hand, four of the factor VIII mutants tested, E110D, D116A, E122A, and D126A, showed ϳ25-90-fold increases in K d for Ca 2ϩ binding compared with wild type, indicating a marked reduction in affinity for the metal ion and suggesting a possible role for these residues in forming a Ca 2ϩ binding site. Comparison of the results obtained for E122D and E122A showing an ϳ3-and ϳ30-fold reduction in Ca 2ϩ affinity suggested the conserved substitution was relatively benign compared with the Ala substitution. A similar disparity was observed for mutation at Glu 110 , where the Asp substitution yielded an ϳ25-fold reduction in affinity whereas substitution with Ala appeared to eliminate the Ca 2ϩ binding site. These results suggested a significant role for these residues, especially Glu 110 , in Ca 2ϩ binding. . Thus, the value for the activity response varied depending upon the particular mutation rather than the metal ion used to saturate the response, suggesting that the activity response could result from modest changes in conformation that were unrelated to the specific metal-ion binding event. Therefore, with respect to this particular site in the A1 domain, both Ca 2ϩ and Mn 2ϩ generate activity by a mechanism affecting a common region crucial for cofactor function.
In contrast, although we observed markedly reduced Ca 2ϩ affinities for E122A and D126A, the affinity of these factor VIII mutations for Mn 2ϩ was either only marginally (ϳ2-fold) reduced or unchanged, respectively. We did observe an ϳ8-fold reduction in Mn 2ϩ affinity for the mutant D116A (compared with a ϳ40-fold reduction in Ca 2ϩ affinity), and this result may suggest a role for b Factor VIII activity is expressed as factor Xa generated (nm/min/nm factor VIII). c Relative activity (% of wild type).
exogenous metal ion (C ϭ 3.2% and 7.2% for Ala and Asp substitutions), the mutation D125A retained significant activity (C ϭ 41%). This observation indicated that mutation at Asp 125 did not likely result in any global change in conformation that would diminish factor VIII activity. This observation adds strong support to our conclusion that Asp 125 participates in the coordination of either Ca 2ϩ or Mn 2ϩ .
DISCUSSION
Previously, we found that Ca 2ϩ (or Mn 2ϩ ) binding to factor VIII HC was essential for cofactor activity (19, 20) . We now identify and tentatively localize a Ca 2ϩ binding site in the A1 domain of factor VIII, the occupancy of which yields an increase in specific activity. Furthermore, the observation that Ca 2ϩ binding to A2 domain in HC contributes little if at all to generate cofactor activity highlights the functional role of the Ca 2ϩ binding site in A1 domain in HC. Recently, Zeibdawi et al. (22) reported that residues 94 -110 in factor V comprise a Ca 2ϩ binding site required for its activity. In the current study, we probed the homologous region in the A1 domain of factor VIII (residues 110 -126) for Ca 2ϩ binding using a site-directed mutagenesis approach. Our results show that mutation at each of several acidic amino acids ( , and C2 (gray) were drawn using an atomic surface model. The region indicated by the white arrow in panel A was magnified and is shown in panels B and C at slightly different angles. The region 102-126 was drawn in ribbon format with the designations: red (␣-helix), green (␤-strand), and white (loop). The region 2133-2140 in the C1 domain was drawn using a stick model format without side chains (red for oxygen, blue for nitrogen, and white for carbon).
the legend to Fig. 3 (20) and further suggest that these sites are in close proximity to one another. Mechanism(s) by which Ca 2ϩ (or Mn 2ϩ ) generate active factor VIII remain largely unknown. The factor VIII A domain homology model (30) predicts residues 102-116 not to possess a defined secondary structure, whereas residues 120 -125 form an ␣-helix with a short ␤ strand segment (residues 117-119) connecting the two segments (Fig. 5) . This coordination would provide appropriate energy to fix in space the elongated region defined by 110 -116. Furthermore, it is of interest to note that in the five-domain factor VIII model (31) , this region juxtaposes the C1 domain (see Fig. 5 ). Although A1 and A3 domains appear to associate with a relatively extended interface, the interface between A1 and C1 is small. Thus, we speculate that stabilizing a segment in A1 near C1 may add structure to a "hinge" region separating the A and C domains.
The above hypothesis is reinforced by our results obtained with Mn 2ϩ , which is typically coordinated by acidic residues and/or His residues (32 Overall, the stabilization we propose to result from metal ion binding near the A1-C1 junction may be necessary to provide proper orientation of factor VIIIa subunits within the factor Xase complex. Significant data indicate an extended interface between factor VIIIa and factor IXa, mediated by residues in A2 and A3 domains of the cofactor (see Ref. 33 for review). Although residues in A3 appear to provide the majority of the binding energy for this interaction (34), critical contacts between A2 subunit and the protease domain of factor IXa are required for cofactor function (35) . The latter is borne out by the direct stimulation of factor IXa by the isolated A2 subunit (36) . Although A1 subunit does not appear to contact factor IXa directly, inclusion of isolated A1 subunit results in a marked enhancement of the activity attributed to the isolated A2 subunit (37) . Thus, A1 appears to function to orient A2 relative to the factor IXa protease domain. This property is further illustrated by truncation of A1 at Arg 336 resulting in a dramatic loss in cofactor activity without significantly altering the inter-A1-A2 subunit affinity (38) .
Factor VIII HC and LC associate in the absence of metal ion (19) . Conformational events suggested by the current study may reflect the stabilization of the A1 110 -126 region, followed by formation of a stable interface between this region and the region around His 2137 in the C1 domain. We identified the presence of at least two Ca 2ϩ sites in isolated A1 subunit by ITC following its treatment with EDTA. The large entropy change observed upon binding Ca 2ϩ was consistent with a significant change in conformation of this domain as suggested above. The affinity value measured for the sites (ϳ0.7 M) was similar to the value we obtained monitoring the increase in specific activity (1.18 M for B-domainless wild type factor VIII). Furthermore, the fractional stoichiometry observed for occupancy of the isolated domain may suggest a dimerization of the subunit that is not observed with the intact heterodimer. The relationship of Ca 2ϩ sites in the A1 domain with other sites in factor VIII has not yet been established. Although we observed passive removal of a putative Ca 2ϩ molecule(s) from the site we propose within residues 110 -126, other metal ions likely remain associated, as judged by the relatively high specific activity of the protein in solutions free from exogenous metal ions. Based upon the observation that pretreatment of EDTA-treated factor VIII LC with Ca 2ϩ was required to obtain reconstitution of functional factor VIII (19), we speculate that Ca 2ϩ contained within sites in the LC may be retained in the absence of chelation. In support of this contention, preliminary data by ITC suggest the presence of multiple Ca 2ϩ sites in the factor VIII LC. 2 Several drawbacks to a loss-of-function mutagenesis approach in the localization of Ca 2ϩ binding sites have been noted. These include mutation to an Ala eliminating total Ca 2ϩ binding (29) , or the elimination of charged residues far removed from a Ca 2ϩ binding site (39, 40) that result in reduced Ca 2ϩ affinity. However, the results presented in this report are further supported by a recent, similar approach applied to the Ca 2ϩ binding site in factor V. The region comprising residues 110 -126 in factor VIII is highly homologous to residues 96 -112 in factor V (Fig. 6) . Recent data generated following site-directed mutagenesis within this region indicates that Glu 96 , Asp 102 , and Asp 111 appear to be crucial residues for the association of factor Va HC and LC (41) , an interaction that is Ca 2ϩ -dependent in factor Va (17 
